英文别名：
Norgestrel;Norgestrel [USAN:INN:BAN:JAN];(+-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one;dl-13-beta-Ethyl-17-alpha-ethynyl-17-beta-hydroxygon-4-en-3-one;dl-13-beta-Ethyl-17-alpha-ethynyl-19-nortestosterone;18,19-Dinor-17-alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (+-)-;18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-,(17alpha)-(+-)-;Norgestrel (DL-);Levonorgestrel;(±)-Norgestrel;fh122-a;monovar;Neogest;NORPLANT;Ovrette;sh850;wy3707;(17α)-(±)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one;DL-13b-Ethyl-17a-ethynyl-17b-hydroxygon-4-en-3-one;17-beta-Hydroxy-18-methyl-19-nor-17-alpha-pregn-4-en-20-yn-3-one;NSC-744007;Q416950;PORTIA COMPONENT LEVONORGESTREL;13-ethyl-17alpha-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one;Ovoplex 30-150;SH-850;Jadelle;Z1544404028;Wy-5104;ORSYTHIA COMPONENT LEVONORGESTREL;Nordette 28;Microlut;Norgestrelum [INN-Latin];Norgestrel (JP17/USP/INN);TWIRLA COMPONENT LEVONORGESTREL;AFIRMELLE COMPONENT LEVONORGESTREL;LEVONORGESTREL COMPONENT OF CLIMARA PRO;Triquilar ED;(-)-Norgestrel, 98%;13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one;Norgestrel [Progestins];13-ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one;Rigevidon 21+7;Levonorgestrel (JAN/USP/INN);Plan B One Step;LEVONORGESTREL COMPONENT OF TWIRLA;CRYSELLE COMPONENT NORGESTREL;Prestwick0_000773;NORGESTREL [EP MONOGRAPH];Prestwick1_000773;(-)-17alpha-Ethynyl-18-methyl-19-nortestosterone;Levonorgestrel [USAN:USP:INN:BAN];NCGC00159349-02;NORGESTREL [MI];TRIVORA COMPONENT LEVONORGESTREL;(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one;BCP9000852;LEVONORGESTREL [WHO-DD];(-)-Levonorgestrel;18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-(-)-;Triciclor;LEVONORGESTREL [USP-RS];ELIFEMME COMPONENT LEVONORGESTREL;Mirena;Norplant (TN);17alpha-Ethynyl-13-ethyl-19-nortestosterone;BPBio1_000932;LEVONORGESTREL [USP IMPURITY];SR-01000759218-5;Norgestrelum;KYLEENA COMPONENT LEVONORGESTREL;LEVONORGESTREL [JAN];18,19-DINORPREGN-4-EN-20-YN-3-ONE, 13-ETHYL-17-HYDROXY-, (17alpha)-(+/-)-;NORGESTREL [HSDB];17alpha-Ethynyl-18-homo-19-nortestosterone;DL Norgestrel;LMST02030119;LEVONORGESTREL COMPONENT OF QUASENSE;BRN 2391114;BAY 86-5028;BAY86-5028;Trinordiol 21;17alpha-Ethynyl-18-homo-19-nor-testosterone;1lhv;NORGESTIMATE IMPURITY B [EP IMPURITY];CCRIS 6525;Opera_ID_552;19-Nortestosterone, 17-ethynyl-18-methyl-;HMS3649J10;MLS000069491;Stediril 30;HMS1570K08;Levonorgestrel for system suitability 1;(+-)-Norgestrel;CCG-100853;PREVEN COMPONENT LEVONORGESTREL;Kyleena;Levonorgestrel implant;HY-B0257;NorLevo;Preven;Ovral-Lo;L-4455;Microgynon CD;D(-)-Norgestrel, analytical standard;Levonelle;Levora-21;Norplant System in Plastic Container;Levonorgestrel, European Pharmacopoeia (EP) Reference Standard;HMS2232K12;Postinor;Nordette 21;DTXSID3047477;MFCD00199013;Next choice;Levlen ED;Tox21_111593;EN300-122613;dl-Norgestrel;Norgestrel, (-)-;LEVONORGESTREL [WHO-IP];Minivlar 30;Microlution;LEVONORGESTREL COMPONENT OF ALESSE;HMS2090O06;(-)-Norgestrel;NORGESTREL [MART.];NORGESTREL [WHO-DD];Monofeme 28;(1R,3aS,3bR,9aR,9bS,11aS)-11a-ethyl-1-ethynyl-1-hydroxy-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one;Levonorgestrel for system suitability 2, European Pharmacopoeia (EP) Reference Standard;NORGESTREL COMPONENT OF CRYSELLE;13beta-ethyl-17alpha-ethynyl-17beta-hydroxy-gon-4-en-3-one;17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one;Levonorgestrel, United States Pharmacopeia (USP) Reference Standard;Prestwick3_000773;BRD-K35189033-001-03-0;LEVONORGESTREL COMPONENT OF LYBREL;INTROVALE COMPONENT LEVONORGESTREL;PLASTIC IUD WITH LEVONORGESTREL;Microgest ED;18,19-Dinor-4-pregnen-20-yn-3-one;UNII-5W7SIA7YZW;LEVONORGESTREL COMPONENT OF INTROVALE;Microluton;LEVONORGESTREL [INN];Microgyn;Triagynon;18,19-Dinor-17-alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-;(-)-18,19-Dinor-13beta-ethyl-17beta-hydroxy-4-pregnen-20-yn-3-one;Microgynon 28;s1727;18-Methylnorethisterone;5W7SIA7YZW;EINECS 229-433-5;Norgestrel (-)-form;LNG;GTPL2881;NORGESTREL [USAN];Wy 3707;(17?)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-yn-3-one;NORGESTREL COMPONENT OF OVRAL;DB00367;(-)-13-ETHYL-17-HYDROXY-18,19-DINOR-17.ALPHA.-PREGN-4-EN-20-YN-3-ONE;D-(-)-Norgestrel beta-D-Glucuronide;CHEBI:6443;Methylnorethindrone;SEASONALE COMPONENT LEVONORGESTREL;NCGC00159349-03;Trinordiol 28;SEASONIQUE COMPONENT LEVONORGESTREL;LEVLITE COMPONENT LEVONORGESTREL;18,19-DINORPREGN-4-EN-20-YN-3-ONE, 13-ETHYL-17-HYDROXY-, (17.ALPHA.)-(-)-;LEVONORGESTREL COMPONENT OF OPCICON ONE-STEP;HMS3886K18;NSC 744007;Levonorgestrel(Levonelle);NCGC00256735-01;Levonorgestrelum [INN-Latin];Prestwick2_000773;N0889;SR-01000946725-1;FH 122-A;Tox21_202872;(+/-)-13-ETHYL-17-HYDROXY-18,19-DINOR-17alpha-PREGN-4-EN-20-YN-3-ONE;VIENVA COMPONENT LEVONORGESTREL;LEVONORGESTREL COMPONENT OF SEASONIQUE;NC00103;3J8Q1747Z2;MLS001074069;CAS-797-63-7;17alpha-ethynyl-17beta-hydroxy-18a-homoestr-4-en-3-one;LEVONORGESTREL [MART.];LEVONORGESTREL [USP MONOGRAPH];D-(-)-Norgestrel;CAS-6533-00-2;6533-00-2;Norplant II;SMR000653526;Tox21_303658;NSC-757251;NCGC00159349-05;Microgynon 30 ED;NORGESTREL [INN];OPCICON ONE-STEP COMPONENT LEVONORGESTREL;13beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one;NORGESTREL (USP-RS);Triphasil 21;LOSEASONIQUE COMPONENT LEVONORGESTREL;QUASENSE COMPONENT LEVONORGESTREL;rel-(8R,9S,10R,13S,14S,17R)-13-Ethyl-17-ethynyl-17-hydroxy-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one;HMS2051M08;AKOS015894913;SMR000059117;MLS001423967;Wy-3707;Plan B One-Step;NORGESTREL (USP MONOGRAPH);NORGESTREL [JAN];NORGESTREL (-)-FORM [MI];Mirena (TN);SR-01000759218;18-Methyl-17-alpha-ethynyl-19-nortestosterone;NORGESTREL (EP MONOGRAPH);LEVONORGESTREL COMPONENT OF LEVONEST;HMS3714K08;Intrauterine levonorgestrel;alpha-Norgestrel;Trifeme 28;NORGESTREL [USP MONOGRAPH];LEVONORGESTRELUM [WHO-IP LATIN];NORGESTREL (MART.);BIDD:PXR0194;UNII-3J8Q1747Z2;18,19-Dinor-13beta-ethyl-17beta-hydroxy-4-pregnen-20-yn-3-one;Levogel;Triphasil 28;Levonova;Ovrette (TN);Microval;LEVONORGESTREL COMPONENT OF ALTAVERA;13-Ethyl-17alpha-ethynyl-17-hydroxygon-4-en-3-one;Neogynon 21;Levosert;(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one (non-preferred name);LEVONORGESTREL COMPONENT OF LEVLITE;Ld norgestrel;ENPRESSE COMPONENT LEVONORGESTREL;D00950;Prestwick_109;SH 850;HSDB 6483;Norgestrel-(-)-D;13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one;(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one;Levonorgestrelum;BSPBio_000846;DTXSID3036496;HMS2097K08;Levonorgestrel, British Pharmacopoeia (BP) Reference Standard;HSDB 3595;LYBREL COMPONENT LEVONORGESTREL;797-63-7;Trigoa;Nordet;CLIMARA PRO COMPONENT LEVONORGESTREL;SCHEMBL27597;LEVONORGESTREL COMPONENT OF LOSEASONIQUE;LEVONORGESTREL [VANDF];TRIPHASIL COMPONENT LEVONORGESTREL;WWYNJERNGUHSAO-XUDSTZEESA-N;NORGESTREL [ORANGE BOOK];LEVONEST COMPONENT LEVONORGESTREL;Plan B;D-Norgestrel;Microgynon 21;D00954;Fallback Solo;NCGC00257283-01;17-alpha-Ethynyl-13-ethyl-19-nortestosterone;Oral levonorgestrel;LEVONORGESTREL [ORANGE BOOK];Ovranette;d(-)-Norgestrel;OPILL;LEVONORGESTREL [EP MONOGRAPH];SH-70850;SR-01000946725;Tri-Levlen 21;Skyla (TN);LEVONORGESTREL COMPONENT OF SETLAKIN;[18,(17.alpha.)-(-)-];MLS000759484;NORDETTE COMPONENT LEVONORGESTREL;17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol;s5709;13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one;LEVONORGESTREL COMPONENT OF PREVEN;LD norgestrel [French];AMY40476;NSC744007;Levonorgestrel (Levonelle);13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one;NCGC00260418-01;Levonorgestrel 100 microg/mL in Acetonitrile;SH 70850;DTXCID1016496;Logynon ED;(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one;ALESSE COMPONENT LEVONORGESTREL;Norplant 2;17-Ethynyl-18-methyl-19-nortestosterone;Levonorgestrel implants;BDBM50410522;CHEMBL1389;13beta-ethyl-17alpha-ethynyl-17-hydroxy-gon-4-en-3-one;NORGESTREL [USP-RS];IMPLANT WITH LEVONORGESTREL;QUARTETTE COMPONENT LEVONORGESTREL;MYZILRA COMPONENT LEVONORGESTREL;17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one;Skyla;MARLISSA COMPONENT LEVONORGESTREL;C08149;NORGESTREL [VANDF];NSC 759653;Norgestrel [USAN:USP:INN:BAN:JAN];HMS2232H06;FH-122A;(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one;NS00067059;CHEBI:50901;KURVELO COMPONENT LEVONORGESTREL;Levonorgestrel, Pharmaceutical Secondary Standard; Certified Reference Material;NSC 757251;Tox21_303623;DTXCID401079284;Liletta;LEVONORGESTREL [USAN];LEVONORGESTREL [HSDB];Levonorgestrel for system suitability 2;LESSINA COMPONENT LEVONORGESTREL;(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one;18,19-DINORPREGN-4-EN-20-YN-3-ONE, 13-ETHYL-17-HYDROXY-, (17.ALPHA.)-(+/-)-;C08153;LNG-IUS;Levora-28;SPBio_002785;CCRIS 9033;LEVORA COMPONENT LEVONORGESTREL;CHEBI:7630;[(-)-13-ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one;13-Ethyl-17alpha-ethynylgon-4-en-17beta-ol-3-one;OVRAL COMPONENT NORGESTREL;Follistrel;NS00002177;EINECS 212-349-8;Tox21_111593_1;(17alpha)-dl-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3- one;E-Gen-C;(+/-)-13-ETHYL-17-HYDROXY-18,19-DINOR-17.ALPHA.-PREGN-4-EN-20-YN-3-ONE;ALTAVERA COMPONENT LEVONORGESTREL;18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-(+-)-;LEVONORGESTREL COMPONENT OF KYLEENA;LEVONORGESTREL COMPONENT OF SEASONALE;SETLAKIN COMPONENT LEVONORGESTREL;AVIANE COMPONENT LEVONORGESTREL;dl-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20- yn-3-one;17-Ethynyl-18-methyl-19-nortestosterone Glucuronide; Levonorgestrel Glucuronide;;(+/-)-NORGESTREL;BRD-K35189033-001-26-1;
3371991952 
